571P Preclinical evaluation of FAP-2286, a peptide-targeted radionuclide therapy (PTRT) to fibroblast activation protein alpha (FAP)
暂无分享,去创建一个
U. Reineke | J. Xiao | T. Harding | N. Beindorff | C. Smerling | A. Hoehne | A. Bredenbeck | F. Osterkamp | A. D. Simmons | D. Zboralski | A. Schumann | M. Paschke | M. Nguyen | A. Mohan